FDA Inspection 801922 — GlaxoSmithKline Manufacturing S.p.A.
The FDA completed an inspection of GlaxoSmithKline Manufacturing S.p.A. on September 21, 2012 in Torrile. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- September 21, 2012
- Fiscal Year
- 2012
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Torrile (Italy)